Education
About Us
Working with TipRanks
Follow Us
Grace Therapeutics (GRCE)
NASDAQ:GRCE
| Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | - | - | - | $ 120.00K | - |
| Operating Income | $ -12.85M | $ -18.25M | $ -15.34M | $ -10.72M | $ -24.44M |
| EBITDA | $ -14.67M | $ -51.85M | $ -9.87M | $ -18.97M | $ -22.12M |
| Net Income | $ -12.85M | $ -42.43M | $ -9.22M | $ -19.89M | $ -25.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 73.30M | $ 79.12M | $ 128.62M | $ 62.46M | $ 24.76M |
| Total Debt | $ 0.00 | $ 485.00K | $ 295.00K | $ 86.00K | $ 147.00K |
| Net Debt | $ -23.00M | $ -27.41M | $ -43.37M | $ -60.65M | $ -14.09M |
| Total Liabilities | $ 11.56M | $ 11.17M | $ 20.35M | $ 6.80M | $ 9.86M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -12.24M | $ -15.93M | $ -17.23M | $ -14.39M | $ -23.27M |
| Operating Cash Flow | $ -12.33M | $ -15.91M | $ -17.23M | $ -14.32M | $ -22.95M |
| Investing Cash Flow | |||||
| Financing Cash Flow |